Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2023, 2024.
-
Busy address KBO
36 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Quality In Treatment from Leuven, company number BE0525829575, closed financial year 2025 with a result of € 33,617 after tax. For that financial year Quality In Treatment recorded a gross margin of € 167,339 and equity of € 158,119. Compared with financial year 2024, the result moved from € 128,326 to € 33,617. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 158,119
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,617
▼ 74% vs 2024
Profit after tax over the fiscal year.
€ 8,477
▼ 58% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -204,168.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 116,268
▼ 31% vs 2024
€ 47,148 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 45,522
▲ 82% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,066
▼ 45% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 120,124 | € -25,114 | € 285,923 | € 167,339 | ▼ 41% |
| Profit after taxes | € -1,139 | € -196,940 | € 128,326 | € 33,617 | ▼ 74% |
| Equity | € 13,117 | € -3,824 | € 124,502 | € 158,119 | ▲ 27% |
| Total debts | € 352,021 | € 277,024 | € 210,446 | € 172,289 | ▼ 18% |
| Cash | - | € 14,396 | € 20,059 | € 8,477 | ▼ 58% |
| Retained profit | € -169,171 | € -366,111 | € -237,785 | € -204,168 | ▲ € 33,617 |
| Bank debt | € 122,523 | € 222,658 | € 168,246 | € 116,268 | ▼ 31% |
| Balance sheet total | € 365,138 | € 273,200 | € 334,948 | € 330,408 | ▼ 1% |
Key figures of Quality In Treatment, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Quality In Treatment?
What happened at Quality In Treatment in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 33,617 (▼ 74% vs 2024). Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,139 loss in 2022 to € 33,617 profit in 2025.
Best year ever: 2024, with € 128,326 profit.
A new publication or filing at Quality In Treatment? We notify you, reason included.
Follow Quality In TreatmentDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Panenco Group comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Quality In TreatmentBehind Quality In Treatment are Panenco Group BV and Nele Stinckens. The shares are held by Panenco Group (60%).
Directors
According to the 2025 annual accounts
Director · represented by Egwin Avau
Nele Stinckens
Director
Shareholders
60%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kapeldreef 60
3001 Leuven
Koning Albertlaan 104
3010 Leuven
Active since 8 April 2013
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 36 companies are registered at this address.
All companies at this address →Belgische Vereniging voor Oppervlaktetechnieken van Materialen
INNOVATIE- EN INCUBATIECENTRUM K.U. LEUVEN
€ 271,378 gross margin · 2025
Vlaamse Jonge Ondernemingen
€ 1.7 million gross margin · 2025
Metis Instruments & Equipment
€ 466,525 gross margin · 2025
Move Online
€ 235,355 gross margin · 2025
+31 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0525.829.575
- VAT number
- BE 0525.829.575
- Registered office
- Kapeldreef 60, 3001 Leuven
- Names & denominations
- Quality In Treatment · QIT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 April 2013
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Literaire creatie
Organisatie van congressen en beurzen
Detailhandel in ICT-apparatuur
Activiteiten van persagentschappen
Persagentschappen
+3